Jan 11 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2017 Nov 30, 2016 May 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 270.84 247.04 552.40
(+9.6 pct) (+14.1 pct) (+9.9 pct)
Operating 10.29 11.88 20.00
(-13.4 pct) (+29.8 pct) (-10.1 pct)
Recurring 11.59 13.04 22.50
(-11.1 pct) (+28.2 pct) (-8.5 pct)
Net 7.78 8.68 15.30
(-10.4 pct) (+41.5 pct) (-16.0 pct)
EPS 393.00 yen 438.58 yen 772.74 yen
Ann Div 80.00 yen 90.00 yen
-Q2 div 45.00 yen 35.00 yen
-Q4 div 45.00 yen 45.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T
((Tokyo Headline News Desk +813 6441 1812))